In-vivo
Big news this morning with acquisition of Definiens by MedImmune, strengthening MedImmune's focus on the discovery of novel predictive biomarkers in immune-oncology. Good news for patients and their providers. Tuesday, 4 November 2014 -...
Visualize, Quantify, Analyze and Phenotype Immune Cells In Situ With PerkinElmer’s cancer immunology research solution, you can simultaneously investigate the spatial relationships between multiple types of immune and other cells within...
The Digital Pathology Association (DPA), a non-profit organization that facilitates education and awareness of digital pathology applications, is featuring Dr. Richard Levenson as the opening presenter for day two of their upcoming annual...
PRWEB - July 29, 2014 The "Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate...
A number of genetic diseases give their petients unique facial characteristics, Down’s syndrome probably being the most famous. While some physicians are able to spot specific diseases, there hasn’t been a systematic way of using facial...
Courtesy of AMA Wire Several major media sources report on research presented at the American Society of Clinical Oncology conference on immune therapies for different cancers. NBC Nightly News (6/2, story 5, 2:25, Curry) reported, “In...
